VillageLife
Senior Member
- Messages
- 674
- Location
- United Kingdom
From ME/CFS forums.....
The press conference will be held on Sept. 18th from approximately 11:00am to noon. It will be streamed our website (cii.columbia.edu), and you can expect an announcement on our website/Twitter (@CII722) with links to the specific pages on Friday/Monday.
------------------
EDIT
------------------
http://cii.columbia.edu/blog.htm?LOfRcb
CII Press Conference
September 18th, 2012
10:30 AM (EDT)
“Multicenter Study on Chronic Fatigue Syndrome/Myalgic Encephalomyelitis”
The causes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) have long eluded scientists. In 2009/2010, two high-profile papers linked the syndrome to infection with a mouse retrovirus called XMRV (xenotropic murine leukemia virus (MLV)-related virus) and murine retrovirus-like sequences (designated pMLV: polytropic MLV). Given that affected patients often have symptoms consistent with a chronic infection, this viral connection was deemed plausible, and the findings were celebrated as a major achievement for a complex disease that afflicts nearly 1 million in the U.S.
However, follow-up investigations by several laboratories were unable to detect XMRV or pMLV in CFS patients.
To definitively resolve this issue, the National Institute of Allergy and Infectious Diseases commissioned a large-scale, multicenter study under the auspices of the Center for Infection and Immunity at Columbia University’s Mailman School of Public Health, in partnership with the Centers for Disease Control and Prevention, the Food and Drug Administration, the NIH’s National Cancer Institute and Warren G. Magnuson Clinical Center, and others (see full list below).
Investigators from the multicenter study on CFS/ME and XMRV/pMLV will discuss their findings and future directions.
A live video will be posted below.
For attendance at the event, members of the media should RSVP by 9:00AM on Monday, Sept. 17th to Nsikan Akpan (212-342-9051 | nea2107@columbia.edu) or Stephanie Berger, Mailman School of Public Health (212-305-4372 | sb2247@columbia.edu).
When: Tuesday, September 18, 2012
Press Conference begins at 10:30 AM (EDT)
Who: W. Ian Lipkin, MD (Moderator)
Center for Infection and Immunity (CII), Mailman School of Public Health, Columbia University
Principal Investigator and Director of Center for Infection and Immunity
John Snow Professor of Epidemiology
Professor of Neurology and Pathology
Harvey Alter, MD
National Institutes of Health, Department of Transfusion Medicine
Distinguished NIH Investigator
Chief, Clinical Studies
Associate Director of Research
Mady Hornig, MD
Center for Infection and Immunity, Mailman School of Public Health, Columbia University
Director of Translational Research at CII
Associate Professor of Epidemiology
Judy Mikovits, PhD
Mikovits Consulting
Francis Ruscetti, PhD
National Cancer Institute, Frederick National Laboratory for Cancer Research
Head, Leukocyte Biology Section
Senior Investigator
Collaborating Research Groups:
Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD.
Mikovits Consulting, Oxnard, CA.
Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
Cancer and Inflammation Program, Frederick National Laboratory for Cancer Research, Frederick, MD.
Tissue Safety Laboratory, Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD.
Nova Southeastern University, Fort Lauderdale FL.
Miami Veterans Affairs Medical Center, Miami, FL.
Brigham and Women’s Hospital, Boston, MA.
Infectious Disease Clinic, Stanford University, Palo Alto, CA.
Fatigue Consultation Clinic, Salt Lake City, UT.
Levine Clinic, New York, NY.
Simmaron Research Institute, Incline Village, NV.
Department of Biostatistics, Columbia University, New York, NY.
Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY.
Center for Infection and Immunity, Columbia University, New York, NY.
Department of Molecular Biology and Microbiology, Tufts University, Boston, MA.
The press conference will be held on Sept. 18th from approximately 11:00am to noon. It will be streamed our website (cii.columbia.edu), and you can expect an announcement on our website/Twitter (@CII722) with links to the specific pages on Friday/Monday.
------------------
EDIT
------------------
http://cii.columbia.edu/blog.htm?LOfRcb
CII Press Conference
September 18th, 2012
10:30 AM (EDT)
“Multicenter Study on Chronic Fatigue Syndrome/Myalgic Encephalomyelitis”
The causes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) have long eluded scientists. In 2009/2010, two high-profile papers linked the syndrome to infection with a mouse retrovirus called XMRV (xenotropic murine leukemia virus (MLV)-related virus) and murine retrovirus-like sequences (designated pMLV: polytropic MLV). Given that affected patients often have symptoms consistent with a chronic infection, this viral connection was deemed plausible, and the findings were celebrated as a major achievement for a complex disease that afflicts nearly 1 million in the U.S.
However, follow-up investigations by several laboratories were unable to detect XMRV or pMLV in CFS patients.
To definitively resolve this issue, the National Institute of Allergy and Infectious Diseases commissioned a large-scale, multicenter study under the auspices of the Center for Infection and Immunity at Columbia University’s Mailman School of Public Health, in partnership with the Centers for Disease Control and Prevention, the Food and Drug Administration, the NIH’s National Cancer Institute and Warren G. Magnuson Clinical Center, and others (see full list below).
Investigators from the multicenter study on CFS/ME and XMRV/pMLV will discuss their findings and future directions.
A live video will be posted below.
For attendance at the event, members of the media should RSVP by 9:00AM on Monday, Sept. 17th to Nsikan Akpan (212-342-9051 | nea2107@columbia.edu) or Stephanie Berger, Mailman School of Public Health (212-305-4372 | sb2247@columbia.edu).
When: Tuesday, September 18, 2012
Press Conference begins at 10:30 AM (EDT)
Who: W. Ian Lipkin, MD (Moderator)
Center for Infection and Immunity (CII), Mailman School of Public Health, Columbia University
Principal Investigator and Director of Center for Infection and Immunity
John Snow Professor of Epidemiology
Professor of Neurology and Pathology
Harvey Alter, MD
National Institutes of Health, Department of Transfusion Medicine
Distinguished NIH Investigator
Chief, Clinical Studies
Associate Director of Research
Mady Hornig, MD
Center for Infection and Immunity, Mailman School of Public Health, Columbia University
Director of Translational Research at CII
Associate Professor of Epidemiology
Judy Mikovits, PhD
Mikovits Consulting
Francis Ruscetti, PhD
National Cancer Institute, Frederick National Laboratory for Cancer Research
Head, Leukocyte Biology Section
Senior Investigator
Collaborating Research Groups:
Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD.
Mikovits Consulting, Oxnard, CA.
Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
Cancer and Inflammation Program, Frederick National Laboratory for Cancer Research, Frederick, MD.
Tissue Safety Laboratory, Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD.
Nova Southeastern University, Fort Lauderdale FL.
Miami Veterans Affairs Medical Center, Miami, FL.
Brigham and Women’s Hospital, Boston, MA.
Infectious Disease Clinic, Stanford University, Palo Alto, CA.
Fatigue Consultation Clinic, Salt Lake City, UT.
Levine Clinic, New York, NY.
Simmaron Research Institute, Incline Village, NV.
Department of Biostatistics, Columbia University, New York, NY.
Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY.
Center for Infection and Immunity, Columbia University, New York, NY.
Department of Molecular Biology and Microbiology, Tufts University, Boston, MA.
